Pubblicazioni

Immune checkpoint inhibitors and pre-existing antinuclear antibodies: the rheumatologist point of view

2021 - CLINICAL & TRANSLATIONAL ONCOLOGY

Ceccarelli, F.; Botticelli, A.; Natalucci, F.; Olivieri, G.; Cirillo, A.; Alessandri, C.; Marchetti, P.; Conti, F.

A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations

2021 - CLINICAL & TRANSLATIONAL ONCOLOGY

Alongi, F.; Nicosia, L.; Figlia, V.; De Sanctis, V.; Mazzola, R.; Giaj-Levra, N.; Reverberi, C.; Valeriani, M.; Osti, M. F.

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study

2020 - CLINICAL & TRANSLATIONAL ONCOLOGY

Gobbini, E; Chiari, R; Pizzutillo, P; Bordi, P; Ghilardi, L; Pilotto, S; Osman, G; Cappuzzo, F; Cecere, F; Riccardi, F; Scotti, V; Martelli, O; Borra, G; Maiello, E; Rossi A, ; Graziano, P; Gregorc, V; Casartelli, C; Sergi, C; Del Conte, A; Delmonte, A; Bareggi C, ; Cortinovis, D; Rizzo, P; TabbÃ², F; Rossi, G; Bria, E; Galetta, D; Tiseo, M; Di, Maio M; Novello, S

Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis

2019 - CLINICAL & TRANSLATIONAL ONCOLOGY

Camerini, A; Banna, G L; Cinieri, S; Pezzuto, A; Mencoboni, M; Rosetti, F; Figueiredo, A; Rizzo, P; Ricci, A; Langenhoven, L; Santo, A; Addeo, A; Amoroso, D; Barata, F